Search research articles
Contact Us
Filters
Showing results (71-80 of 130) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement
Kala Visvanathan, Laura A Levit, Derek Raghavan, et al.
The Lancet. Oncology
|
February 14, 2009
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I Scher, Xiaoyu Jia, Johann S de Bono, et al.
Investigational New Drugs
|
February 26, 2013
A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer
Robert Dreicer, Jorge Garcia, Brian Rini, et al.
Human Pathology
|
October 30, 2020
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity
Claud M Grigg, Chad Livasy, Jiaxian He, et al.
Endocrine-Related Cancer
|
August 4, 2020
Management changes for patients with endocrine-related cancers in the COVID-19 pandemic
Derek Raghavan, Antoinette R Tan, E Shannon Story, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2012
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology
Lowell E Schnipper, Thomas J Smith, Derek Raghavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2013
American Society of Clinical Oncology 2013 top five list in oncology
Lowell E Schnipper, Gary H Lyman, Douglas W Blayney, et al.
JCO Oncology Practice
|
June 8, 2021
Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem
Derek Raghavan, Nicole A Keith, Hughes R Warden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Reply to L.k. Griffeth et al and J.E. Battley et al
Lowell E Schnipper, Richard L Schilsky, J Russell Hoverman, et al.
Urologic Oncology
|
June 9, 2023
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites
Earle F Burgess, Chad A Livasy, James T Symanowski, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 130) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 31, 2017
Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement
Kala Visvanathan, Laura A Levit, Derek Raghavan, et al.
The Lancet. Oncology
|
February 14, 2009
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I Scher, Xiaoyu Jia, Johann S de Bono, et al.
Investigational New Drugs
|
February 26, 2013
A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer
Robert Dreicer, Jorge Garcia, Brian Rini, et al.
Human Pathology
|
October 30, 2020
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneity
Claud M Grigg, Chad Livasy, Jiaxian He, et al.
Endocrine-Related Cancer
|
August 4, 2020
Management changes for patients with endocrine-related cancers in the COVID-19 pandemic
Derek Raghavan, Antoinette R Tan, E Shannon Story, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 12, 2012
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology
Lowell E Schnipper, Thomas J Smith, Derek Raghavan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2013
American Society of Clinical Oncology 2013 top five list in oncology
Lowell E Schnipper, Gary H Lyman, Douglas W Blayney, et al.
JCO Oncology Practice
|
June 8, 2021
Levine Cancer Institute Financial Toxicity Tumor Board: A Potential Solution to an Emerging Problem
Derek Raghavan, Nicole A Keith, Hughes R Warden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2014
Reply to L.k. Griffeth et al and J.E. Battley et al
Lowell E Schnipper, Richard L Schilsky, J Russell Hoverman, et al.
Urologic Oncology
|
June 9, 2023
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites
Earle F Burgess, Chad A Livasy, James T Symanowski, et al.
Page
of 13